Related Experiment Videos
A model of DNA damage response activation at stalled replication forks by SPRTN
Christopher Bruhn1, Marco Foiani2,3
1IFOM (Istituto FIRC di Oncologia Molecolare), Via Adamello 16, 20139, Milan, Italy.
Nature Communications
|December 14, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nucleoporin TPR integrates MAPK signaling with mitogen-induced transcriptional programs.
Cell death & disease·2026
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone.
The Journal of clinical investigation·2025
DNA damage response regulator ATR licenses PINK1-mediated mitophagy.
Nucleic acids research·2025
Catalyst-controlled regiodivergence in enantioselective synthesis of spirocyclic γ- versus δ-lactams.
Nature communications·2026
Carbon distribution in planet Mercury from magma ocean evolution to graphite crust and core composition.
Nature communications·2026
A new core-genome MLST approach for Chlamydia trachomatis genomic surveillance and research.
Nature communications·2026
Wireless IoT-enabled microneedle electroceutical for personalized and connected pain management.
Nature communications·2026
A programmable lipid-triggered allosteric site modulates LC3 LIR receptor binding activity.
Nature communications·2026
Staple crops as a key hub of biogeochemical mercury cycle across China.
Nature communications·2026
A Monte Carlo based dose verification tool for an HDR Ir-192 brachytherapy source and its evaluation on extremity malignancies.
Journal of applied clinical medical physics·2026
Pulmonary ventilation images from planning CT images using deep learning on locally-advanced NSCLC patients.
Journal of applied clinical medical physics·2026
Herpetic reactivation during radiotherapy treatment for gynaecological cancers-a retrospective observational study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Radiodynamic Therapy Using Local Administration of 5-Aminolevulinic Acid for In Vivo Osteosarcoma Xenograft Model.
In vivo (Athens, Greece)·2026